vs
EverQuote, Inc.（EVER）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是EverQuote, Inc.的1.1倍（$207.3M vs $195.3M），EverQuote, Inc.净利率更高（29.6% vs -62.0%，领先91.6%），EverQuote, Inc.同比增速更快（32.5% vs 25.9%），EverQuote, Inc.自由现金流更多（$25.8M vs $-100.8M），过去两年EverQuote, Inc.的营收复合增速更高（46.5% vs 38.0%）
EverQuote, Inc.是一家创立于2011年的在线保险比价交易平台，总部位于美国马萨诸塞州剑桥市，致力于连接保险消费者与合适的保险服务商，为用户提供便捷的线上保险选购对接服务。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
EVER vs RARE — 直观对比
营收规模更大
RARE
是对方的1.1倍
$195.3M
营收增速更快
EVER
高出6.6%
25.9%
净利率更高
EVER
高出91.6%
-62.0%
自由现金流更多
EVER
多$126.6M
$-100.8M
两年增速更快
EVER
近两年复合增速
38.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $195.3M | $207.3M |
| 净利润 | $57.8M | $-128.6M |
| 毛利率 | 97.7% | — |
| 营业利润率 | 9.5% | -54.7% |
| 净利率 | 29.6% | -62.0% |
| 营收同比 | 32.5% | 25.9% |
| 净利润同比 | 369.3% | 3.5% |
| 每股收益（稀释后） | $1.53 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVERRARE
| Q4 25 | $195.3M | $207.3M | ||
| Q3 25 | $173.9M | $159.9M | ||
| Q2 25 | $156.6M | $166.5M | ||
| Q1 25 | $166.6M | $139.3M | ||
| Q4 24 | $147.5M | $164.6M | ||
| Q3 24 | $144.5M | $139.5M | ||
| Q2 24 | $117.1M | $147.0M | ||
| Q1 24 | $91.1M | $108.8M |
净利润EVERRARE
| Q4 25 | $57.8M | $-128.6M | ||
| Q3 25 | $18.9M | $-180.4M | ||
| Q2 25 | $14.7M | $-115.0M | ||
| Q1 25 | $8.0M | $-151.1M | ||
| Q4 24 | $12.3M | $-133.2M | ||
| Q3 24 | $11.6M | $-133.5M | ||
| Q2 24 | $6.4M | $-131.6M | ||
| Q1 24 | $1.9M | $-170.7M |
毛利率EVERRARE
| Q4 25 | 97.7% | — | ||
| Q3 25 | 97.3% | — | ||
| Q2 25 | 96.9% | — | ||
| Q1 25 | 96.8% | — | ||
| Q4 24 | 96.3% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 95.7% | — | ||
| Q1 24 | 94.5% | — |
营业利润率EVERRARE
| Q4 25 | 9.5% | -54.7% | ||
| Q3 25 | 10.1% | -106.9% | ||
| Q2 25 | 9.0% | -64.8% | ||
| Q1 25 | 4.8% | -102.6% | ||
| Q4 24 | 8.2% | -74.3% | ||
| Q3 24 | 8.1% | -94.6% | ||
| Q2 24 | 5.4% | -79.1% | ||
| Q1 24 | 1.9% | -151.9% |
净利率EVERRARE
| Q4 25 | 29.6% | -62.0% | ||
| Q3 25 | 10.8% | -112.8% | ||
| Q2 25 | 9.4% | -69.0% | ||
| Q1 25 | 4.8% | -108.5% | ||
| Q4 24 | 8.3% | -80.9% | ||
| Q3 24 | 8.0% | -95.7% | ||
| Q2 24 | 5.5% | -89.5% | ||
| Q1 24 | 2.1% | -156.8% |
每股收益（稀释后）EVERRARE
| Q4 25 | $1.53 | $-1.28 | ||
| Q3 25 | $0.50 | $-1.81 | ||
| Q2 25 | $0.39 | $-1.17 | ||
| Q1 25 | $0.21 | $-1.57 | ||
| Q4 24 | $0.35 | $-1.34 | ||
| Q3 24 | $0.31 | $-1.40 | ||
| Q2 24 | $0.17 | $-1.52 | ||
| Q1 24 | $0.05 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $171.4M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $238.0M | $-80.0M |
| 总资产 | $326.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EVERRARE
| Q4 25 | $171.4M | $421.0M | ||
| Q3 25 | $145.8M | $202.5M | ||
| Q2 25 | $148.2M | $176.3M | ||
| Q1 25 | $125.0M | $127.1M | ||
| Q4 24 | $102.1M | $174.0M | ||
| Q3 24 | $82.8M | $150.6M | ||
| Q2 24 | $60.9M | $480.7M | ||
| Q1 24 | $48.6M | $112.3M |
股东权益EVERRARE
| Q4 25 | $238.0M | $-80.0M | ||
| Q3 25 | $174.9M | $9.2M | ||
| Q2 25 | $170.3M | $151.3M | ||
| Q1 25 | $149.5M | $144.2M | ||
| Q4 24 | $135.4M | $255.0M | ||
| Q3 24 | $117.7M | $346.8M | ||
| Q2 24 | $100.8M | $432.4M | ||
| Q1 24 | $88.3M | $140.3M |
总资产EVERRARE
| Q4 25 | $326.9M | $1.5B | ||
| Q3 25 | $256.1M | $1.2B | ||
| Q2 25 | $241.4M | $1.3B | ||
| Q1 25 | $232.1M | $1.3B | ||
| Q4 24 | $210.5M | $1.5B | ||
| Q3 24 | $180.5M | $1.5B | ||
| Q2 24 | $158.0M | $1.6B | ||
| Q1 24 | $135.4M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.0M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $25.8M | $-100.8M |
| 自由现金流率自由现金流/营收 | 13.2% | -48.6% |
| 资本支出强度资本支出/营收 | 0.6% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.47× | — |
| 过去12个月自由现金流最近4个季度 | $90.3M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流EVERRARE
| Q4 25 | $27.0M | $-99.8M | ||
| Q3 25 | $19.8M | $-91.4M | ||
| Q2 25 | $25.3M | $-108.3M | ||
| Q1 25 | $23.3M | $-166.5M | ||
| Q4 24 | $20.1M | $-79.3M | ||
| Q3 24 | $23.6M | $-67.0M | ||
| Q2 24 | $12.4M | $-77.0M | ||
| Q1 24 | $10.4M | $-190.7M |
自由现金流EVERRARE
| Q4 25 | $25.8M | $-100.8M | ||
| Q3 25 | $18.5M | $-92.7M | ||
| Q2 25 | $23.8M | $-110.7M | ||
| Q1 25 | $22.2M | $-167.8M | ||
| Q4 24 | $19.1M | $-79.5M | ||
| Q3 24 | $22.1M | $-68.6M | ||
| Q2 24 | $11.5M | $-79.0M | ||
| Q1 24 | $9.7M | $-193.9M |
自由现金流率EVERRARE
| Q4 25 | 13.2% | -48.6% | ||
| Q3 25 | 10.6% | -58.0% | ||
| Q2 25 | 15.2% | -66.5% | ||
| Q1 25 | 13.3% | -120.5% | ||
| Q4 24 | 13.0% | -48.3% | ||
| Q3 24 | 15.3% | -49.2% | ||
| Q2 24 | 9.8% | -53.7% | ||
| Q1 24 | 10.6% | -178.2% |
资本支出强度EVERRARE
| Q4 25 | 0.6% | 0.5% | ||
| Q3 25 | 0.7% | 0.8% | ||
| Q2 25 | 0.9% | 1.5% | ||
| Q1 25 | 0.7% | 1.0% | ||
| Q4 24 | 0.7% | 0.1% | ||
| Q3 24 | 1.0% | 1.2% | ||
| Q2 24 | 0.7% | 1.4% | ||
| Q1 24 | 0.8% | 3.0% |
现金转化率EVERRARE
| Q4 25 | 0.47× | — | ||
| Q3 25 | 1.05× | — | ||
| Q2 25 | 1.72× | — | ||
| Q1 25 | 2.92× | — | ||
| Q4 24 | 1.64× | — | ||
| Q3 24 | 2.04× | — | ||
| Q2 24 | 1.93× | — | ||
| Q1 24 | 5.47× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EVER
| Automotive | $179.9M | 92% |
| Home And Renters | $15.4M | 8% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
